The R1 RCM Inc (RCM) share price is expected to increase by 8.14% over the next year. This is based on calculating the average 12-month share price estimate provided by 4 stock analysts who have covered RCM. Price targets range from $14.3 at the low end to $19 at the high end. The current analyst consensus for RCM is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
R1 RCM Inc has a total of 4 Wall St Analyst ratings. There are 1 buy ratings, 3 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that R1 RCM Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of RCM.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Sarah James Cantor Fitzgerald | Neutral | $14.3 | Reiterates | Oct 4, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $14.3 | Reiterates | Aug 20, 2024 |
Jailendra Singh Truist Securities | Hold | $14.3 | Maintains | Aug 8, 2024 |
Charles Rhyee TD Cowen | Hold | $14.3 | Downgrade | Aug 5, 2024 |
Michael Cherny Leerink Partners | Market Perform | $14.3 | Downgrade | Aug 1, 2024 |
Richard Close Canaccord Genuity | Buy | $15 | Maintains | Jul 22, 2024 |
George Hill Deutsche Bank | Hold | $16 | Maintains | Jul 9, 2024 |
Craig Hettenbach Morgan Stanley | Overweight | $17 | Maintains | Jul 8, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $20 | Reiterates | Jul 2, 2024 |
Vikram Kesavabhotla Baird | Outperform | $18 | Maintains | Jul 2, 2024 |
Sean Dodge RBC Capital | Outperform | $19 | Reiterates | Jun 28, 2024 |
Sean Dodge RBC Capital | Outperform | $19 | Reiterates | Jun 11, 2024 |
Richard Close Canaccord Genuity | Buy | $15 | Maintains | May 9, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $20 | Reiterates | Apr 10, 2024 |
Scott Schoenhaus Keybanc | Sector Weight | Downgrade | Apr 10, 2024 | |
Jack Wallace Guggenheim | Buy | $15 | Maintains | Apr 5, 2024 |
Jailendra Singh Truist Securities | Hold | $16 | Maintains | Apr 1, 2024 |
Craig Hettenbach Morgan Stanley | Overweight | $17 | Reiterates | Mar 26, 2024 |
Richard Close Canaccord Genuity | Buy | $16 | Maintains | Mar 20, 2024 |
Daniel Grosslight Citigroup | Buy | $16 | Upgrade | Mar 20, 2024 |
When did it IPO
2015
Staff Count
29,400
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Lee Rivas
Market Cap
$6.04B
In 2023, RCM generated $2.25B in revenue, which was a increase of 24.79% from the previous year. This can be seen as a signal that RCM's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Planet DDS, a cloud-based dental practice management provider, reports strong growth in 2024 with new product improvements and partnerships, positioning itself for a record-breaking year.
Why It Matters - Planet DDS's advancements and partnerships signal strong growth potential, likely boosting revenue and market position, which could lead to increased investor confidence and share value.
Summary - R1 RCM has transitioned to a privately held company, with Joe Flanagan being reappointed as CEO.
Why It Matters - R1 RCM's transition to a privately held company may impact its growth strategy and financial transparency, affecting future investment opportunities and valuations.
Summary - R1 RCM Inc. reported a quarterly loss of $0.05 per share, better than the expected loss of $0.15, compared to break-even earnings per share a year earlier.
Why It Matters - R1 RCM's smaller-than-expected loss indicates improving financial performance, potentially boosting investor confidence and affecting stock valuation positively.
Summary - R1 RCM INC's Q3 2024 revenue and EPS indicate business performance; investors should compare these metrics with Wall Street estimates and year-ago figures for context.
Why It Matters - Comparing R1 RCM's revenue and EPS to Wall Street estimates and prior year figures provides insights into performance trends and market expectations, influencing investor sentiment and stock valuation.
Summary - Levi & Korsinsky, LLP is investigating R1 RCM Inc (NASDAQ: RCM) for potential breaches of fiduciary duties by its board, affecting shareholders who purchased stock before February 23, 2024.
Why It Matters - The investigation into R1 RCM's board may signal potential legal issues or governance concerns, impacting shareholder confidence and stock performance.
Summary - Levi & Korsinsky, LLP is investigating R1 Rcm Inc (NASDAQ: RCM) for potential breaches of fiduciary duties by its board, affecting shareholders who bought stock before February 23, 2024.
Why It Matters - The investigation into R1 RCM's board may indicate potential governance issues, impacting stockholder confidence and possibly affecting the company's stock price.